Fitaro It is a newer formulation of Semaglutide and unlike Ozempic and Wegovy, a lot of studies have not been done on Fitaro
Notably, the STEP (Semaglutide Treatment Effect in People with obesity) trials, which specifically examined body composition, demonstrated substantial weight loss compared with placebo (NCT03548935) [53], and reductions in fat mass and visceral adipose tissue were accompanied by decreases in lean mass, although the proportion of lean mass relative to total body mass increased (NCT04074161) [54]
Whether you are taking any other supplements, such as our GLP-1 Daily Support supplement, to help manage your journey
PlexusDx adjusts your dose escalation timeline based on your tolerance, ensuring steady progress without unnecessary suffering
Lab work and body-composition estimates are informational and not a substitute for medical care